Thrombosis Events May Be Clarified By e-CYPHER Data Expected In February

FDA's public health notification related to adverse events for J&J/Cordis' Cypher is intended to generate further data collection for the drug-eluting stent rather than raise undue concern over clotting issues, the agency says

More from Archive

More from Medtech Insight